Ocugen Inc (OCGN)
0.6963 x 50 0.7188 x 3
Post-market by (Cboe BZX)
0.7077 -0.0115 (-1.60%) 04/28/25 [NASDAQ]
0.6963 x 50 0.7188 x 3
Post-market 0.6963 -0.0114 (-1.61%) 18:47 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -54,054 | -63,078 | -86,804 | -58,365 | -21,822 |
Depreciation Amortization | 1,968 | 522 | 381 | 229 | 102 |
Other Working Capital | 3,665 | -13,156 | 9,195 | 2,490 | -1,210 |
Other Operating Activity | 6,279 | 13,658 | 17,149 | 7,705 | 8,221 |
Operating Cash Flow | $-42,142 | $-62,054 | $-60,079 | $-47,941 | $-14,709 |
Cash Flows From Investing Activities | |||||
PPE Investments | -3,385 | -10,476 | -4,457 | -939 | -307 |
Net Acquisitions | N/A | N/A | N/A | -127 | N/A |
Purchase Of Investment | N/A | -3,947 | -12,510 | -750 | N/A |
Sale Of Investment | N/A | 17,500 | N/A | N/A | N/A |
Investing Cash Flow | $-3,385 | $3,077 | $-16,967 | $-1,816 | $-307 |
Cash Flows From Financing Activities | |||||
Debt Issued | 30,000 | 500 | 500 | N/A | 921 |
Debt Repayment | N/A | N/A | N/A | -10 | -5,649 |
Common Stock Issued | 38,556 | 20,804 | 59,567 | 129,211 | 37,822 |
Other Financing Activity | -3,698 | -423 | -592 | -8,525 | -1,483 |
Financing Cash Flow | $64,858 | $20,881 | $59,475 | $120,676 | $31,611 |
Exchange Rate Effect | 28 | -5 | 25 | N/A | N/A |
Beginning Cash Position | 39,462 | 77,563 | 95,109 | 24,190 | 7,595 |
End Cash Position | 58,821 | 39,462 | 77,563 | 95,109 | 24,190 |
Net Cash Flow | $19,359 | $-38,101 | $-17,546 | $70,919 | $16,595 |
Free Cash Flow | |||||
Operating Cash Flow | -42,142 | -62,054 | -60,079 | -47,941 | -14,709 |
Capital Expenditure | -3,385 | -10,476 | -4,457 | -939 | -307 |
Free Cash Flow | -45,527 | -72,530 | -64,536 | -48,880 | -15,016 |